THE AMINO ACID COMPOSITION OF HYPERTENSIN II AND ITS BIOCHEMICAL RELATIONSHIP TO HYPERTENSIN I by Lentz, Kenneth E. et al.
THE AMINO ACID  COMPOSITION OF HYPERTENSIN II AND 
ITS  BIOCHEMICAL RELATIONSHIP TO HYPERTENSIN I 
BY KENNETH E. LENTZ, PH.D., LEONARD T. SKEGGS, JR., PH.D., KENNETH R. 
WOODS, PH.D., JOSEPH R. KAHN, M.D., AND NORMAN 
P. SHUMWAY, M.D. 
(From the Department of Medicine and Surgery, Veterans Administration 
Hospital, and the Department of Pathology, Western Reserve 
University, Clevdand) 
(Received for publication, April 13, 1956) 
Hypertensin has been demonstrated in the arterial bloods of many patients 
with hypertensive cardiovascular disease (1)  as well as in dogs with experi- 
mental renal hypertension (2). Purification of this material led to the  demon- 
stration of the existence of two peptides with pressor  activities (3).  Both of 
these peptides, designated hypertensin I  and hypertensin II, have been puri- 
fied (4, 5). The amino acid composition of hypertensin I and its electrophoretic 
properties have been reported (6). An enzyme present in plasma and requiring 
chloride ion for activation  was found  to be necessary for the  conversion of 
hypertensin I  to hypertensin II (3). This enzyme has been partially  purified, 
and is referred to as the hypertensin-converting enzyme (7). Recent work with 
isolated aortic strips suggested (8),  and perfusion studies in the isolated rat 
kidney subsequently demonstrated (7)  that hypertensin I  itself has no vaso- 
constrictor properties. Hypertensin II, formed by the action of the converting 
enzyme on hypertensin I, was shown to be the substance responsible for vaso- 
constriction and the elevation of blood pressure produced by the renin-hyper- 
tensin system. 
Carboxypeptidase is useful in  the elucidation  of polypeptide and  protein 
structure by virtue of its ability to hydrolyze most carboxyl terminal peptide 
bonds with the release  of amino acids (9). Study of the action of this enzyme 
on hypertensin  I  and hypertensin  II has permitted  an identification  of the 
peptide bond hydrolyzed by the converting enzyme, and also a determination 
of the carboxyl terminal amino acid sequences of both peptides. 
EXPERIMENTAL 
Amino Acid Composition of Hypertensin II.-- 
A sample of hypertensln II (5) containing 5.46 rag.  of solids (0.88 rag.  of N  with 12,000 
Goldblatt units of pressor activity) was hydrolyzed in 2 ml. of 6 N HC1 for 21.5 hours at 
ll0°C. The hydrolysate, colorless  and free of particles, was chromatographed on a  100 cm. 
dowex 50  X  8  ion exchange column by the procedure of Moore and  Stein  (10).  Effluent 
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fractions were analyzed  by  the improved ninhydrin  method  of Moore and  Stein  (11).  A 
duplicate hydrolysate was prepared from 3.28  rag.  of solids  containing 0.53  rag.  of N  with 
7,250  Goldblatt  units.  This  was  chromatographed  and  analyzed  in  the  same  manner  as 
the first sample. In order to obtain quantitative recoveries of the basic amino acids, a  third 
sample, containing 5.46 rag.  of solids  (0.88 rag.  of N) was hydrolyzed and chromatographed 
on a  15 cm. dowex 50 X  8 column as described by Moore and  Stein  (10).  The effluent pat- 
tern of the first sample from the I00 cm. column is given in Fig. 1 which shows the pres- 
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Fro.  1. Effluent patterns from a  100 cm. dowex-50  X  8 ion exchange column 
ence of aspartic acid, praline,  valine, isoleucine,  tyrosine, phenylalanine, histidine, and  ar- 
ginine in hypertensin II. 
The quantitative data for the two samples  chromatographed on  100  cm. 
columns are presented in Table I, which for comparison also includes the molar 
amino acid composition  of hypertensin I  (6). The identity of isoleucine was 
confirmed  by  paper  chromatography using  a  water-tertiary amyl  alcohol 
solvent and Whatman No.  4 paper.  When compared  with reference  leucine 
and isoleucine standards the unknown amino acid was indistinguishable  from 
isoleucine. 
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tensin  I  in  that  it contains no leucine and  only one mole of histidine.  The 
minimum  molecular weight would be 1305 for hypertensin  I  and  1036 for 
hypertensin II if it is assumed that both molecules are straight chain mono- 
meric polypeptides. 
The leucine and histidine present in hypertensin I, but not accounted for in 
hypertensin II, were sought in the filtrate which had resulted from the salting- 
out of hypertensin II following its formation from hypertensin I by the con- 
verting enzyme (5). 
TABLE  I 
Amino Acid Analysis of Hypertensin  II 
Aspartic acid 
Proline 
Valine 
Isoleucine 
Tyrosine 
Phenylalanlne 
Histidine 
Arginine:~ 
Leucine 
Total 
Nitrogen as per cent of 
total nitrogen 
1  2 
per cent #er vent 
6.41  7.00 
7.29  6.82 
7.01  7.18 
6.14  6.42 
5.76  6.80 
6.20  6.22 
16.82  19.30 
26.00  29.85 
81.63  89.59 
Aver, 
#er cent 
6.70 
7.06 
7.10 
6.28 
6.28 
6.21 
18.06 
27.93 
85.62 
Amino acid residues 
per 100 gin. of sample 
1  2  t  Aver. 
/ 
I 
gm.  gm.  gm. 
9.78  10.661  10.22 
i 
9.59  8.97~  9.28 
9.39  9.611  9.50 
9.23  9.63  9.43 
11.95  14.081  13.02 
11.74  11.74  11.74 
9.97  11.41  10.69 
13.00  14.85  13.93 
84.64  90.95  87.81 
Molsr  proportions 
Hypertensin II  Hyper- 
tensin 
1  I  2  Aver.  I* 
[ 
M  M  M  M 
1.01  1.03  1.02  1.03 
1.14  1.00  1.07  1.03 
1.10  1.06  1.08  1.03 
0.97  0.95  0.96  0,95 
0.91  1.00  0.96  0.96 
0,98  0.92  0.95  1.04 
0.88  0.95  0,92  1.87 
1.02  1.10  1.06  0.99 
1.09 
* Data of Skeggs eta/. (6). 
~t Calculated from the ratio of arginine to histidine found using the 15 cm. dowex 50 X  8 
column for basic amino acids. 
This filtrate had been saturated with sodium chloride and  contained small amounts  of 
unprecipitated hypertensin II and unconverted hypertensin I,  as well as impurities intro- 
duced  by the converting enzyme preparation.  It was first extracted with secondary butyl 
alcohol at pH  1.4.  The extract gave positive tests for ninhydrin-reaetive material and for 
histidine when analyzed by the diazotized sulfanilic acid colorimetric method  (12). It was 
distributed in a  200 tube Craig-Post countercurrent machine using 0.05 N HC1-5  per cent 
NaCI as the stationary phase and secondary butyl alcohol as the mobile phase. After 270 
transfers, active pressor material was located in tubes 140 to 170, using the rat assay tech- 
nique of Skeggs e$ al. (13). Tubes 50 to 90 were found to contain material which gave posi- 
tive histidine and niahydrin tests but did not increase the blood pressure of a  rat when as- 
sayed  for pressor activity.  The  buffer phase  containing this latter fraction was  collected 
from the machine and  evaporated  to  dryness under reduced pressure.  From the dry resi- 
due, material giving a  positive histidine reaction equivalent to 8.6 mg. of histidine was ex- 
tracted with secondary butyl alcohol. Appropriate aliquots of this butanol-soluble material 
were daromatographed on Whatman No.  4  paper using butanol-acetic acid-water solvent 186  AMINO  ACID  COMPOSITION  OF  HYPERTENSIN  II 
(4:1:5). A single spot having an average Rf value of 0.47 was obtained upon development 
with ninhydrin. Leucine and histidine standards when chromatographed in the same man- 
ner,  gave average R  I  values of 0.63 and 0.15, respectively, demonstrating  that the histi- 
dine-reactive material  was not free histidine.  After hydrolysis in constant boiling hydro- 
chloric acid under reflux conditions for 21 hours  the histidine-reactive material  gave two 
spots  corresponding precisely with histidine  and  leudne when  chromatographed  exactly 
as before. When the hydrolyzed material was mixed with unhydrolyzed material and chro- 
matographed three spots were obtained. When mixed with leucine and histidine and chro- 
matographed,  it was indistinguishable from them. 
These results show that the hypertensin-converting  enzyme acts as a  pepti- 
dase,  splitting histidine and leucine from hypertensin I  as an intact peptide. 
The N-terminal amino acid of  the  dipeptide was  determined by Sanger's 
fluorodinitrobenzene  technique (14) as modified by Levy (15). 
The  dipeptide,  after  reaction  with  fluorodinitrobenzene, followed by hydrolysis  with 
constant boiling hydrochloric acid, was chromatographed on Whatman No. 4 paper.  Bis° 
dinitrophenylhistidine and dinitrophenyileucine, as well as free histidine and leucine were 
used  as  reference standards.  One yellow spot  corresponding to  bisdinitrophenylhistidine 
was  obtained  in the  butanol-acetic acid-water  solvent.  On  spraying  the  chromatogram 
with ninhydrin a single blue spot corresponding to free leucine was found. Neither free his- 
tidine nor dinitrophenylleucine was found. 
The fluorodinitrobenzene  technique thus established the amino acid sequence 
of the dipeptide as histidylleucine. 
Action of Carboxypeptidase  on  ttypertensin  I.-- 
A 0.2 ml. suspension of carboxypeptidase (Nutritional Biochemical Co., Cleveland) was 
twice washed with cold water and then resuspended in 10 ml. of 0.1 per cent sodium bicar- 
bonate solution. Molar  sodium hydroxide was added  until the  suspension just dissolved, 
whereupon the pH was quickly adjusted to 8.0 by the addition of dilute hydrochloric acid. 
Aliquots of the enzyme solution prepared in this manner were used in each of the experi- 
ments. 
In the first experiment 5 ml. of a solution of hypertensin I at pH 8.0 containing 5.25 rag. 
of solid (0.84 rag. of N, with 8,100 Goldblatt units of activity)  was incubated with 0.10 ml. 
of the carboxypeptidase preparation  at 38°C. for 165 minutes. At various intervals during 
incubation suitable  aliquots  of  the  reaction  mixture  were withdrawn  and the  enzymatic 
activity was quickly destroyed by boiling. Each  aliquot was analyzed for uinhydrin reac- 
tive material  and also assayed for pressor activity in the rat. 
The results, illustrated in Fig. 2,  indicate that soon after initiation of the 
reaction  there  was  an  increase  in  ninhydrin-reactive material,  presumably 
due to splitting of the peptide, which continued for  160 minutes. It is note- 
worthy that pressor activity diminished very rapidly, but returned to a  con- 
siderable extent after 30 minutes, only to decrease  again until at the end of 
the  experiment there  was  virtually no  activity remaining. This observation 
was  confirmed  upon  repetition  of  the  experiment. 
The appearance of amino acids in the samples withdrawn as the reaction LENTZ, SKEGGS, WOODS, KAHN, AND S~AY  187 
proceeded  was studied by paper chromatography. After 165 minutes leucine, 
histidine, and phenylalanine were the only free amino acids found. The pres- 
ence  of a  single peptide was  also  revealed  when the paper  chromatograms 
were stained by Durrum's procedure  (16). This peptide was presumably the 
product of hypertensin I  after degradation to the limit of carboxypeptidase 
action. 
Leucine was  the first amino acid to be liberated in major quantities and 
appeared during the first 10 minutes of the incubation. Histidine next appeared, 
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FIG. 2. Incubation of hypertensin I  with carboxypeptidase 
being  maximally liberated in 25  minutes, and phenylalanine appeared last, 
increasing in amount until 145 minutes. This qualitative interpretation of the 
sequence in which the amino acids were liberated was based on a visual esti- 
mate of the relative intensities of the ninhydrin spots resulting from chro- 
matographs at each time interval. A quantitative procedure  was next devised 
to test the validity of these interpretations. 
In the quantitative experiment separate  2.0  ml. samples containing 2.10  rag.  of hyper- 
tensin I  were incubated at 38°C. for 5,  15, and 90 minutes with 0.0S ml. of the carboxypep- 
tidase preparation.  The reaction was stopped by lowering the pH to 1.5 with hydrochloric 
acid. The sample was evaporated to dryness. The residues were taken up in 2.0 ml. of 0.01 
N HCI and transferred to 0.9 X  15 cm. dowex 50 X  8 columns. The following series of buf- 
fers was used  in eluting the samples:  (a)  0.1  M sodium citrate,  pH 4.00,  to elute leucine; 
(b)  0.I  M sodium  citrate,  pH 4.25,  to elute phenylalanine;  (c)  an  intermediate buffer, 0.1 
sodium citrate, pH 6.7  (15-20  ml.); and  (d)  0.2  x¢ NaHCOs, pH 8.3  to elute histidine. 
These buffers,  except for the pH 4.00  buffer, are those described by Moore and  Stein (10). 188  AMINO  ACID  COMPOSITION  OF  HYPERTENSIN  II 
The results of these experiments, given in Table II,  demonstrate that the first 
amino acid removed from hypertensin  I  by carboxypeptidase is leucine,  the 
second histidine,  and the  third phenylalanine.  Of particular interest  was the 
finding that leucine is the carboxyl terminal amino acid of hypertensin  I  and 
that it is linked through its amino group to the carboxyl of hisfidine.  This is 
the  same  sequence  previously  established  for  the  peptide  histidylleucine, 
obtained by the action of the hypertensin converting enzyme on hypertensin I. 
Action  of  Carboxypeptidase  on  ttypertensin  H.-- 
1.0 ml. of hypertensin II solution containing 1.37 rag. of solid (0.22 rag. of N with 3,000 
Goldblatt units) was chilled in ice and  mixed with 0.1 ml. of cold molar Na2HPO4 buffer 
TABLE II 
Release of Amino Acids from Hypertensin I by Carboxypeptidase 
Leucine 
Histidine 
Phenylalanine 
Products  Time of incubation at 38"C.  Amount of amino acid released 
per ~K* of hypertensin I 
m/n. 
5 
15 
90 
5 
15 
90 
5 
15 
90 
/JM 
0.81 
0.91 
0.67 
0.12 
0.37 
0.82 
0.00 
0.22 
O. 73 
* Based on the tentative minimum molecular weight of 1305. 
containing 0.05 ml. of carboxypeptidase solution. The mixture was incubated at 38°C. and 
samples were withdrawn at 0, 15, 45, 105, and 165 minutes. Each sample was analyzed for 
ninhydrin-reactive material and assayed for pressor activity  in the rat. 
The results are given in Fig. 3. Identity of the ninhydrin-reactive material 
was established by paper chromatography of aliquots from the reaction mix- 
ture  after incubation  for  165  minutes.  With  a  descending  secondary butyl 
alcohol-4 per cent ammonia 3  to  1 system, only one ninhydrin-reactive spot, 
corresponding to phenylalanine, was visible. Chromatography of this material 
alone and  with  reference phenylalanine in  butanol-acetic acid-water gave  a 
single spot in either case. No traces of free phenylalanine could be found when 
a  zero  time sample of the reaction mixture was  similarly chromatographed. 
A second incubation of hypertensin II with carboxypeptidase for 240 minutes 
did  not  result  in  the  appearance  of even  traces  of amino  acids  other  than LENTZ, SKEGGS~  WOODS~ KAHN~ AND  SHUMWAY  189 
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phenylalanine. In this latter experiment 0.90 gM of phenylalanine was liberated 
per #M of hypertensin II. 
It is apparent that the loss in pressor activity of hypertensin II coincides 
with  the liberation of its carboxyl terminal  amino  acid, phenylalanine.  The 
failure  of carboxypeptidase to hydrolyze either  type of hypertensin  beyond 
the release of phenylalanine, suggests that the amino acid present in the pep- 
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Fro. 3. Incubation of hypertensin  II with carboxypeptidase 
160 
tide bond beyond phenylalanine  is proline,  an amino acid which resists the 
attack of carboxypeptidase (10). 
DISCUSSION 
The preparations  of hypertensin  I  and II used in these studies had  each 
previously been purified and isolated as a single component by countercurrent 
distribution.  Hypertensin  II  was found  to  consist  of eight  amino  acids  in 
approximately molar ratios. These eight amino acids, plus the peptide histidyl- 
leucine,  account for the ten amino  acids previously found in hypertensin  I, 
thus providing strong additional  evidence for the purity of the hypertensin 
preparations. 
The action of carboxypeptidase on hypertensin I produced an unusual effect 190  AMINO  ACID  COMPOSITION  O~"  HYPERTENSIN  II 
on  the biological  activity as assayed in  the intact  rat.  The loss  in  activity 
coincident with the first appearance of free amino acids was followed by the 
return  of activity as the amount of liberated amino acids increased.  Finally 
the activity fell to 3 per cent of the initial level. By correlating the sequence 
of appearance of the various free amino acids with the changes in biological 
activity and the demonstration that the vasoconstrictor effect of hypertensin 
II  is  completely destroyed by the removal of phenylalanine  a  tentative  ex- 
planation  of the results may be given. The zero time sample of hypertensin 
I shows high pressor activity because it is readily converted to hypertensia II 
by the converting enzyme present in  the circulating plasma of the rat  used 
for assay. The first abrupt drop in physiological  activity corresponds closely 
to the appearance of free leucine during the first 5 to 15 minutes; at this stage, 
the  converting  enzyme may not  be capable of removing  histidine  to  form 
hypertensin II. The subsequent increase in activity closely parallels  the appear- 
ance of free histidine and therefore of free hypertensin II in the medium. The 
final  drop in  activity, which  corresponds to  the liberation  of phenylalanine, 
would represent the inactivation of hypertensin II. 
SUMMARY 
Preparations of hypertensin II, obtained from the treatment of hypertensin 
I by the action of the hypcrtensin converting enzyme of plasma and purified 
by countercurrent distribution,  were quantitatively  analyzed for their  amino 
acid content.  Chromatography on ion exchange columns showed the presence 
of equimolar amounts of aspartic acid,  proline,  valinc,  isoleucine,  tyrosine, 
phenylalanine,  histidine,  and arginine. 
Hypertensin I was found to contain one mole of leucine  and one mole of 
hisfidine  in addition to the amino acids  of hypcrtensin II. These two amino 
acids  were isolated  from the  conversion  products of  hypertcnsin I  and identified 
as the peptidc histidylleucine. 
Carboxypcpfidasc digestion  of hypertensin I showed the carboxyl terminal 
sequence of amino acids to be residuc--phenylalanyl-histidylleucine.  Similar 
studies of hypcrtensin II demonstrated residue-phenylalanine.  It was con- 
cluded that the conversion of hypcrtensin I by the plasma hypcrtensin con- 
verting enzyme involved hydrolysis of the phenylalanyl-histidine bond  to 
form hypcrtensin II and hisfidylleucine.  The further  removal by carboxy- 
peptidase of phenylalanine from hypertensin II destroyed all of the vaso- 
constrictor  activity. 
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